Experimental tracheal allograft revascularization and transplantation  by Delaere, Pierre R. et al.
EXPERIMENTAL TRACHEAL 
ALLOGRAFT 
REVASCULARIZATION AND 
TRANSPLANTATION 
The feasibility of tracheal allotransplantation with a fascial vascular 
carrier was examined in three groups with varied dose sequences of 
immunosuppression. A control group (group 1) received no medication. 
The three experimental groups were given daily cyclosporine intramuscular 
doses of 5 mg/kg (group 2), 5 mg/kg plus 3 mg/kg methylprednisolone 
(Solu-Medrol) (group 3), and 10 mg/kg (group 4) for 6 weeks or until death. 
Grafts were assessed by silicone dye infusion of the artery of the fascial flap 
to examine their microcirculation a d by quantitative histologic study. 
Group 1 evidenced complete rejection after a heterotopic revascularization 
period of 14 days. The allografts of the experimental groups remained 
viable after 14 days of revascularization and could be transplanted 
orthotopically after this period. After transplantation, the viability of group 
2 tracheas was unpredictable with changes ranging from mild to complete 
rejection. Group 3 evidenced well-preserved transplant viability with infec- 
tion.induced necrosis at the anastomoses caused by the corticosteroid 
component. All group 4 animals survived the follow-up period with normal 
allograft viability. Cyclosporine in a dosage of 10 mg/kg per day can 
etfectively suppress the immune response after transplantation of vascu- 
larized tracheal allografts. This experimental model will allow future 
studies to examine airway wall immunogenicity. (J THORAC CARDIOVASC 
SURG 1995;110:728-37) 
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A lthough more than 50% of the trachea may be resected with direct end-to-end reconstruction, 
the occasional occurrence of extensive disease has 
led to continued interest in tracheal replacement, by
means of either a prosthesis or an allotransplant. 
The major obstacles to successful c inical transplan- 
tation of the trachea have been the immunogenicity 
of the tracheal wall and the restoration of its blood 
supply. 
Experimental transplantation models may be use- 
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ful to study both revascularization a d rejection. 
However, the distinction between avascular and 
rejection ecrosis in these models is possible only if 
the blood supply to the transplant is fully restored. 
Because direct revascularization f tracheal vessels 
can be expected to be associated with significant 
technical problems, indirect revascularization by a 
pedicled flap of omentum or muscle has been used. 
The omentum has been used intensively in exper- 
imental tracheal revascularization with different re- 
sults. Both orthotopic and heterotopic revascular- 
ization studies with omentum are available. These 
two different revascularization models may in part 
be responsible for the confusion around the possi- 
bility of tracheal revascularization. 
The majority of the studies on tracheal revascu- 
larization were done orthotopically with tracheal 
autografts hat were isolated and immediately reim- 
planted wrapped by the transposed omentum. 1-3 
Consequently, the blood supply of the grafts was 
derived from two sources, the neovascularity from 
the recipient rachea t both ends of the graft and 
the supply from the omentum. From these studies, it 
seemed that only the synergistic effects of the two 
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supplies ucceeded in preserving the viability of the 
graft at both ends near the anastomosis. The mid- 
portion of the autograft failed to receive the syner- 
gistic effect and became necrotic. 
Another possibility is to study heterotopic tra- 
cheal revascularization. 4'5 These grafts are com- 
pletely immobile during revascularization a d are 
not exposed to the airway during mucosal regener- 
ation and give better angiogenetic results compared 
with orthotopic revascularization. A disadvantage is 
that only short follow-up times may be studied. 
Mucosal overgrowth at both ends of the graft and 
mucus accumulation will result in intraluminal in- 
fection early after heterotopic transplantation. 
We developed an experimental model that com- 
bined the advantages of both orthotopic and heter- 
otopic revascularization without the disadvantages 
of the two l ocations. A previous animal study on 
tracheal autograft revascularization showed that a 
large arteriovenous bundle and its surrounding vas- 
cularized island of fascia can be induced to perfuse 
a heterotopic transplanted trachea and that this 
allows its orthotopic transfer as a prefabricated 
flap. ó Tracheal revascularization occurred to a 
greater extent by angiogenesis from the fascia 
through the membranous part in a circumferential, 
posterior-anlLerior direction and to a lesser extent 
through the intercartilaginous ligaments. The versa- 
tility of the model allowed for the step-by-step 
evaluation of the revascularization process of het- 
erotopic transplanted tracheal autografts. It was 
established that revascularization a d epithelial re- 
generation are concomitant processes. The time- 
table of the tracheal revascularization process was 
investigated and an optimal revascularization period 
was determined to be between 14 and 20 days. 
Mucosal disintegration was seen if the grafts were 
isolated for a longer period than the optimal revas- 
cularization period because of stagnation of respi- 
ratory secretions and intraluminal infection. At the 
optimal time the revascularized segments were or- 
thotopica!ly transplanted on the fascial vascular 
pedicle. 7
Encouraged by the data on autotransplantation 
we wanted to investigate the feasibility of tracheal 
orthotopic allotransplantation with the lateral tho- 
racic fasc~al flap used as a vascular carrier. The first 
objective of this study was to evaluate the timetable 
of acute tracheal rejection of unprotected rabbit 
allografts.; The second objective was to develop an 
apparently reliable form of experimental tracheal 
transplantation by the combined use of heterotopic 
and orthotopic graft implantation made possible by 
vascular ingrowth from a fascial flap. The minimal 
immunosuppressive dose that allows for long-term 
experimental tracheal allotransplantation in the or- 
thotopic position was determined. This model will 
allow future studies to examine reliably factors that 
affect graft rejection. 
Material and methods 
The experimental nimals used were New Zealand 
White rabbits and Dutch belted rabbits (weight 3000 gm). 
This combination provides a strong histocompatibility 
barrier. Dutch belted rabbits served as donors and New 
Zealand White rabbits were the recipients. Thirty-seven 
rabbits were used. Sixteen tracheal atlografts were studied 
in the control group. Twenty-one animals randomly di- 
vided into three groups (N = 7) and having different 
immunosuppressive protocols underwent tracheal allo- 
transplantation in the experimental group. 
First stage: heterotopic fascia revascularization. Anes- 
thesia was induced in the donor and recipient rabbits with 
intravenous pentobarbital nd maintained with inhaled 
halothane and oxygen through mask ventilation. At the 
reeipient site, the left thoracic fascia was isolated on the 
lateral thoracic vessels. The vascular anatomy and dissee- 
tion technique of this subcutaneously, axially perfused 
sheet of fascia have been described previously. 6 At the 
donor site a cervical tracheal allograft was excised through 
a midline incision in the neck. The trachea was divided 
five rings caudally to the larynx and a segment of 2.5 cm 
was resected. On the outside, the graft was cleared from 
most of the connective tissue and the tracheal lumen was 
flushed with 10 ml of sterile saline solution. The tracheal 
allograft was transferred to the dissected lateral thoracic 
fascial flap of the recipient animal. The donor animal was 
killed with an overdose of pentobarbital sodium (Nembu- 
tal) (100 mg/kg intravenously). The tracheal graft was 
brought over the dissected fascial flap and was stretched 
to its original length (2.5 cm) by attachment to the 
underlying thoracic muscles with Vicryl polyglactin 5/0 
(Ethicon, Inc., Somerville, N.J.) sutures to avoid shrink- 
age of the allograft (Fig. 1). The proximal end of the 
transplant was located at the medial side of the flap. The 
tracheal segment was wrapped in the vascularized fascia 
and then secured with polypropylene stitches. The lateral 
thoracic skin was closed with interrupted sutures. 
Histomorphometry of the allografls in the control group 
(N = 16). To study the timetable of tracheal rejeetion, 
every second day after heterotopic transplantation from 
day 2 to day 16 two rabbits were killed. After the follow-up 
period, the rabbits were premedicated and anesthetized. 
The left axillary region was opened and the left thoracic 
artery of the fascial flap was flushed through the cannula 
with 10 ml of heparinized, normal saline solution (10 IU 
of heparin per milliliter) followed by 5 ml of blue silicone 
dye (Microfil, Canton Bio-Medical Products Inc., Boul- 
der, Colo.). This material formed a cast of the vascular 
architeeture of the fascial flap and the established vascular 
connections with the tracheal allograft. After these injec- 
tions were eompleted, the tracheal segments were re- 
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Fig. 1. Schematic presentation of orthotopic tracheal 
transplantation. 1, Tracheal allograft, stretched to its 
original length (2.5 cm), is wrapped by fascial flap for 
heterotopic revascularization; 2, resection of 2 cm seg- 
ment of native trachea; 3, transplantation f 2 cm revas- 
cularized allograft segment by transposition of pedicled 
fascial flap after 14-day revascularization period. 
moved and fixed in 10% neutral buffered formalin solu- 
tion for light microscopy. Two representative cross sections 
were taken from the middle of each allograft. The tissues 
were embedded in paraffin and 4/xm thick cross sections 
were cut and stained with hematoxylin-eosin (H&E) stain. 
Reperfusion of the allograft after 2, 4, 6, 10, 12, 14, and 
16 days was assessed histomorphometrically by the distri- 
bution of blood vessels in the lamina propria of the 
tracheal segments that were perfused with blue silicone 
dye. Revascularization ccurred in a continuous, circum- 
ferential posterior-anterior di ection and was expressed as 
a percentage of the total tracheal circumference showing 
reperfusion. The values of the two cross sections in the 
two animals for each even day after unprotected revascu- 
larization were added and averaged. 
The amounts of squamoid and ciliated epithelium were 
scanned on the histologic slides and presented as a mean 
percentage and standard error of the total tracheal cir- 
cumference. 
Intermediate angiographic studies in the experimental 
group. The tracheal viability after a revascularization 
period of 14 days was investigated in two animals of 
groups 2, 3, and 4. The rabbits were anesthetized, the left 
axillary region was opened, and the left lateral thoracic 
artery was injected with 5 ml of blue silicone dye. The 
tracheal segments were removed and fixed in 10% neutral 
buffered formalin solution for light microscopy. 
Second stage: orthotopic transplantation. Five ani- 
mals of each experimental group underwent orthotopic 
transplantation after the 14-day revascularization period. 
The tracheal segment and its surrounding fascia were 
resected and the composite island flap pedicled on the 
lateral thoracic vessels was subcutaneously rotated to the 
neck region. The mucosal overgrowth at both ends of the 
allograft was removed and the remaining tracheal äl- 
lograft of 2 cm length was orthotopically transplanted 
after resection of a 2 cm long segment of native trachea 
(Fig. 1). The transplant was oriented in its original 
proximal-distal direction to allow for mucociliary clear- 
ance over the transplanted region. The upper transplant 
anastomosis was done after some sutures were placed on 
the posterior wall of the lower anastomosis. The trans- 
plantation was completed with closure of the anterior 
lower anastomosis with interrupted polypropylene (Pro- 
lene, Ethicon) sutures and closure of the skin incision. 
The animals breathed spontaneously during the entire 
operation. Antibiotics were administered for 4 postoper- 
ative days in both operation stages. Rabbits were housed 
in separate quarters in an environment-controlled facility 
and fed a standard rabbit diet. 
Cyclosporine (Sandimmune, Sandoz) for intravenous 
infusion was diluted to 10 mg/ml. The three experimental 
groups were given cyclosporin A intramuscularly in a daily 
dose of 5 mg/kg (group 2), 5 mg/kg plus methylpred- 
nisolone (Solu-Medrol) 3 mg/kg (group 3), and 10 mg/kg 
(group 4), beginning the day of initial graft transfer. After 
the orthotopic transplantation the animals were followed 
up for 4 weeks or until death. After the follow-up period, 
the rabbits were premedicated and anesthetized with 
pentobarbital sodium (40 mg/kg intraperitoneally). The 
lateral thoracic artery of the fascial flap was exposed and 
cannulated with a 14-gauge catheter and perfused with 
blue silicone rubber at a pressure of 150 mm Hg. Viability 
was assessed with both clinical and histologic parameters 
on the injected tracheal specimen. The same injection 
technique was used immediately after death in the animals 
that died before the end of the follow-up period. In the 
animals that survived for 4 weeks, a high-resolution 
gadolinium-pentetic a id enhanced Tl-weighted spin 
echo sequence was used before the animals were killed to 
obtain a magnetic resonance imaging (MRI) study in the 
coronal, sagittal, and axial planes from the transplanted 
region. 
All animals received humane care in compliance with 
the "Principles of Laboratory Animal Care" formulated 
by the National Society for Medical Research and the 
"Guide for the Care and Use of Laboratory Animals" 
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Fig. 2. Allografl revascularization, squamoid epithelium, and ciliated epithelium scores during hetero- 
topic revascularization in control group. Allograft revascularization score acutely decreased after 10 days 
and after initial progressive r perfusion. Epithelial regeneration from squamoid to ciliated cells was seen 
with progressive vascularization. Ischemic mucosal degeneration evolved flora ciliated cells over squamoid 
cells and basal cells to completely denuded avascular submucosa. Revascularization with mucosal 
regeneration and rejection-mediated c ssation of microcireulation with mucosal dedifferentiation were 
significantly inked. Rejection process terminated when submucosal capillaries of graft involuted and could 
no longer deliver fresh immune cells. 
prepared by the Institute of Laboratory Animal Resources 
and published by the National Institutes of Health (NIH 
Publication No. 86-23, revised 1985). 
Results 
Control group (N = 14). Results are shown in 
Fig. 2 and Fig. 3, A, B, C, and D). 
Mucosal revascularization. Submucosal thrombo- 
sis was noticed in the gratis at 2 days. Revaseular- 
ization started after 4 days in the membranous 
region and evolved in a circumferential posterior- 
anterior direction from day 4 to day 10. A progres- 
sive mononuclear cell migration into the lamina 
propria was seen from day 6 on. After 8 days, areas 
of revascularized blood vessels displayed a mononu- 
clear vasculitis with reactive intimal changes. After 
10 days, the majority of the vessels were throm- 
bosed. After 12 days, no flow and no silicone dye 
were observed in the submucosa of any of the gratis 
and mononuclear cell infiltration decreased rapidly 
within the avascular submucosa. 
Mucosal regeneration. From day 4 on, a squamoid 
epithelial recovery was seen in the posterior egion 
preceding the revascularization process by 2 days. 
The squamoid epithelium recovered from the basal 
cells of the respiratory epithelium that were most 
resistant against ischemia. A differentiation of squa- 
moid to ciliated epithelium was seen with progres- 
sive revascularization. The mucosal regeneration 
and differentiation evolved, like the revasculariza- 
tion process, in a circumferential posterior-anterior 
direction. A breakpoint was reached after 10 days. A 
mucosal degeneration was seen in the allografts with 
progressive damage of the microcirculation. The 
ciliated epithelium curve followed the downward 
slope of the vascularization curve with ischemic 
metaplasia of ciliated cells to squamoid cells. The 
avascular submucosa fter 12 days was lined with 
squamoid and basal cells that completely disap- 
peared after 14 days. Mucosal regeneration and 
degeneration were dependent on the condition of 
the submucosal microcirculation and were not di- 
rectly damaged by the cell-mediated rejection pro- 
cess .  
Cartilage component. Histologic changes similar 
to those in the submucosal microcirculation were 
observed at the external part of the cartilage rings in 
the small contact area with the fascial flap. The 
peritracheal connective tissue between cartilage and 
the fascia was repopulated by blood vessels from day 
2 to day 10. Mononuclear cell invasion around the 
regenerated blood vessels, followed by vasculitis and 
thrombosis, occurred ffom day 10 to day 14. After 
14 days, a fibrous, avascular connective tissue band 
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Fig. 3. Photomicrographs of allograft revascularization a d rejection in group 1: rejection comrols. A, 
Revascularization f tracheal submucosal thrombosis (H&E stain, original magnification ×25). Progressive 
thrombus revascularization cctLrred ffom left thrombus (2: located posteriody) to right thrombus (1: located 
anteriorly). Arrow indicates posterior (P) to anterior (A) direction of graft. Right thrombus is populated by 
silicone spots ( mall arrows) without apparent endothelial lining. Endothelial cells or subendothelial cells (visible 
as black spots) are located in thrombus. Silicone dye-injected vessels are coalesced and obtained endothelial 
lining from donor origin in left thrombus (asterisks). Thrombus undergoes further esorption with progressive 
reperfusion and vessel with magnitude similar to thrombosed vessel will ultimately be formed. Mucosal ining 
is ciliar (ce) over left thrombus and squamoid (se) over right thrombus, indicating concomitant mucosal-vascular 
regeneration evolving in posterior-anterior di ecfion. TL, Tracheal lumen. B, Photomicrograph of allograft 
revascularization a d rejection after 8 days (H&E stain, original magnification ×25) shows well-defined 
perivascular mononuclear cell infiltration on both sides of cartilage graft (white arrows). F, Fascia; TL, tracheal 
1urnen. C, Photomicrograph of allograft after 12 days of revascularization (H&E staln, original magnification 
× 25). Cessation of submucosal microcirctflation with fibrinoid material is seen within vessels (arrows). Epithelial 
lining shows ischemic degeneration to monocellular layer. Cell-mediated rejecfion is not completely extin- 
guished at extemal side of tracheal cartilage (asterisk) after 12 days. F, Fascia; TL, tracheal lumen. D, Photomicro- 
graph of allograft after 16 days of revascularization (H&E stain, original magnification ×25). End stage of 
tracheal rejection with cartilage allograft surrounded by two nearly avascu]ar bands (both double arrows). 
Lamina propria contains vasculonecrotic lesions with significant fibrinoid material. Epithelial lining has 
completely disappeared. Cartilage allograft and fascia (F) are separated by fibrous connective tissue (lower 
double arrows). Cartilage component shows early signs of ischemic necrosis with eosinophilic ground substance 
and resorption. TL, Tracheal lumen. 
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isolated the cartilage graft from the fascia. Early 
signs of avascular necrosis of the cartilage compo- 
nent with eosinophilic hanges of the ground sub- 
stance were observed after 16 days. The end stage was 
a cartilage transplant surrounded by avascular fibrous 
tissue at both the submucosal nd fascial side. 
Experimental group (N = 21) 
Intermediate angiographic studies. The viability of 
the tracheal transplant after a revascularization pe- 
riod of 14 days was preserved in each of the three 
groups without major differences among the groups. 
The submucosal layer was completely revascularized 
and the segments were lined with respiratory epi- 
thelium. Some graft-invading cells consisting pri- 
marily Of lymphocytes and macrophages were seen 
at both sides of the cartilage rings. The cartilage 
component had a normal histologic appearance. 
Grafi status after transplantation 
GROUP 2. Three animals did not survive the fol- 
low-up period and died 12, 15, and 17 days, respec- 
tively, after transplantation of respiratory distress. 
Postmortem acroscopic evaluation displayed com- 
plete necrosis of the transplant mucosa. There was 
an abrupt transition area between the necrotic 
transplant and the native trachea without apparent 
problems alt the anastomosis (Fig. 4, A). Histologic 
evaluation showed acomplete rejection of the donor 
tissues with full-thickness avascular necrosis of the 
tracheal wall. 
Two animals urvived the follow-up period. Apart 
from a more pronounced mononuclear cell infiltra- 
tion in the lamina propria, these two animals dis- 
played the macroscopic and histologic pattern of the 
group 4 animals. 
GROUP 3. The mean survival period of the five 
group 3 animals after orthotopic transplantation was 
6 days. They died of considerable neck infection in 
combination with infection-induced necrosis at the 
upper and lower transplant anastomoses. On mac- 
roscopic evaluation, the transplants had a normal 
viability! The mucosal layer was completely colored 
by the blue silicone dye but necrosis at both anas- 
tomoses led to tracheal obstruction (Fig. 4, B). 
On histologic examination, it was shown that the 
fascial wrap protected the transplant from the infec- 
tious process. Polynuclear cells were visible at the 
outside of the fascia. No fascial protection was 
available at both anastomoses that were damaged by 
the infection in the neck. The middle part of the 
transplant was completely revascularized and lined 
with ciliated epithelium. 
GROUP 4. All the animals survived the follow-up 
period Without respiratory problems. After 4 weeks 
the animals were anesthetized and an MRI study 
was obtained with a gadolinium-pentetic a id en- 
hanced Tl-weighed spin echo sequence. 
The transplanted and the native tracheas had 
comparable airway lumens (Fig. 5, A). On the axial 
image, the mucosal ining and the revascularized 
lamina propria of the transplant were visible as an 
enhancing inner circle that bordered the tracheal 
lumen. The fascial wrap was clearly visible as an 
enhanced outer circle around the tracheal trans- 
plant (Fig. 5, B). 
Macroscopic evaluation of longitudinal sections 
displayed an intact mucosal lining in the area of the 
transplant-native trachea anastomosis. A sharp de- 
marcation was found between the native tracheal 
epithelium and the transplant mucosa injected with 
the blue silicone dye. A lower density of silicone- 
injected blood vessels was present in the native 
tracheal submucosa near the transplant anastomo- 
sis, indicating the neovascular capacity of the tra- 
cheal transplant (Fig. 4, C). 
The histologic features of the transplant were 
similar to those of the findings on intermediate 
angiographic studies. The difference between trans- 
plant and native tracheal morphologic features was 
seen at the anastomotic region. The transplanted 
trachea could be distinguished by the silicone-in- 
jected submucosal vessels and the slight lymphocytic 
infiltration of the lamina propria (Fig. 5, C). 
Discussion 
The results in the eontrol group showed that the 
trachea is an organ subject o the same immunologic 
laws as all other allogeneic tissues. The most impor- 
tant component in tracheal rejection appears to be 
cell-mediated rejection and the presumed prime 
target cell population is allograft endothelium. Mi- 
crovascular thrombosis is the end point in acute 
traeheal rejeetion 10 days after initial progressive 
revascularization a d mucosal regeneration. 
The mucosal rejection process is related to the 
submucosal mieroeireulation. Mononuelear cells, 
provided by the revascularized submucosal blood 
vessels, attack the lamina propria and destroy the 
vessel wall with thrombosis and bloekage of the 
microcirculation and subsequent mucosal degener- 
ation. 
The eartilaginous component of the allograft is 
rejected, like the epithelial cells, as a result of vascular 
ehanges. The cell-mediated vascular ejeetion oc- 
eurs at both sides of the cartilage component. The 
revascularized connective tissue between ¢artilage 
and fascial flap displayed microvaseular rejeetion 
734 Delaere et aL 
The Journal of Thoracic and 
Cardiovascular Surgery 
September 1995 
Fig. 4. Macroscopic view of tracheal transplant anastomosis. A, Group 2 animal. Abrupt transition area is 
seen between necrotic allograft mucosa and normal native tracheal mucosa. No granulation tissue has 
formed at anastomosis. Fascial wrap around transplant (arrow) is injected with silicone dye. This 
macroscopic picture corresponds with complete necrosis induced by chronic rejection of initially revascu- 
larized graft. B, Group 3 animal. Internal ining of transplant is colored by silicone dye, indicating normal 
mucosal viability. Necrosis is seen at anastomosis, an area without fascial protection. Growth of blood 
vessels from transplanted to native trachea is prevented by infectious disruption at anastomosis. C, Group 
4 animal. Viable transplant mucosa (colored with blue silicone dye) with completely healed anastomosis 
(arrows). Silicone-injected blood vessels, induced by fascial flap, are visible on native tracheal mucosa. 
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Fig~ 5. Radiologic and histologic evaluation of group 4 allografts. A, Coronal Tl-weighted spin echo MRI 
section through tracheal transplant (gadolinium-enhanced) shows upper (U) and lower (L) transplant 
anastomoses. Transplanted region (2 cm) represents majority of cervical trachea. B, Axial enhanced 
Tl-we~ghted spin echo MRI demonstrates revascularized tracheal segment with fascial wrap (F). Tracheal 
lumen is lined by hyperintense ring representing revascularized mucosa. C, Photomicrograph of outlined 
segment on A (H&E stain, original magnification × 10). Transplant anastomosis reveals difference between 
native and transplanted trachea. Dense, silicone-injected submucosa and lymphocytic infiltration of lamina 
propria allow for identification of transplanted allograft. Mononuclear cells are present at both sides of 
carfilage in transplanted segment. A, llograft; N, native trachea; F, fascia. Arrow indicates polypropylene 
suture.. 
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signs similar to tbose of the tracheal submucosa with 
mononuclear vasculitis and thrombosis. The immu- 
nologically induced avascularity around the cartilage 
rings isolates the cartilaginous component in a fi- 
brous cocoon with problematic metabolic diffusion. 
Cartilaginous i chemic necrosis results from pericar- 
tilaginous avascularity. 
This observation suggests that the endothelium of 
the revascularized submucosal nd pericartilaginous 
blood vessels is the site of the prime mänifestation 
of the rejection process. The endothelial cells of the 
capillary network, at both sides of the tracheal 
cartilage, are derived from donor vascular endothe- 
lial cells. The donor endothelial cells grow into the 
thrombosed vessels after graft isolation and reline 
the revascularized thrombi, a phenomenon i duced 
by the fascial wrap. This explains the allogeneic 
perivasculitis of the regenerated microcirculation. 
Heterotopic revascularized tracheal allografts 
may successfully be transplanted only when pro- 
tected by immunosuppressive drugs. The immuno- 
suppressive dosages in the three groups were chosen 
to conform with immunosuppressive protocols used 
in other experimental transplantation studies. 8 Cy- 
closporine at 10 mg/kg was clearly capable of pre- 
serving the viability of transplanted tracheas with 
normal healing of anastomoses. Cyclosporine ad- 
ministered at 5 mg/kg resulted in differing histologic 
patterns of rejection after transplantation ranging 
from moderate to complete rejection. The associa- 
tion with methylprednisolone in group 3 animals 
seemed to successfully suppress the immune re- 
sponse but was responsible for the infection seen at 
the operation wounds, which led to airway problems 
at the anastomoses. 
Vascularized fascia is as effective as the omentum 
in the revascularization f airway segments. Possi- 
bly, the nature of the tissue used as a vascular carrier 
is less important. Of major importance is that the 
vascular carrier have axial perfusion and a reliable 
and easily transferable vascular pedicle. For tracheal 
transplantation, one needs a vascular carrier with as 
little bulk as possible to adapt the flap within the 
small tracheoesophageal septum. For this purpose, 
the use of a vascularized sheet of fascia seems 
useful. 
A reliable vascular carrier and a heterotopic 
revascularization stage form the keystone for suc- 
cessful orthotopic transplantation. Tracheal grafts 
are revascularized through the membranous and 
intercartilaginous ligaments. They are revascular- 
ized through the same mechanisms as skin grafts 
with an additional obstacle formed by the cartilage 
rings. 6 For optimal revascularization, it is of utmost 
importance to have a close and immobile contact 
between the graft and vascular bed, and this cannot 
be fulfilled in an orthotopic position in which the 
graft moves with each respiration and swallowing 
act. The heterotopically located transplants are re- 
vascularized equally over the total fascia-enwrapped 
area without restriction on the length of the trans- 
plant. 
This model may become important in the study of 
the morphologic and pathophysiologic features of 
airway wall rejection. Because understanding the 
pathophysiologic process of airway wall rejection is 
largely dependent on animal models, it is important 
to consider the potential shortcomings of the vari- 
ous laryngotracheal rejection models. Larynx and 
trachea contain mucosa nd cartilage and may both 
be used to study the immunogenetic requirements 
for airway wall rejection. Heterotopic laryngeal 8 and 
tracheal transplant 9 models were introduced and 
have been used successfully to study the morpho- 
logic basis of acute rejection. With a heterotopic 
laryngeal transplantation model it was concluded 
that cyclosporine at 7.5 mg/kg and 10 mg/kg was 
capable of preserving the viability of transplanted 
larynges. In a study on rat tracheal allografts that 
were heterotopically revascularized by omental 
wrapping, it was shown that tracheal transplant 
viability was improved with an optimum combina- 
tion of cyclosporine and methylprednisolone. 9 The 
accumulation of mucus secretions in the aerody- 
namic afunctional larynx or trachea is, however, an 
important factor that enhances the development of
graft infection and graft necrosis. 
Orthotopic laryngeal transplantation a d ortho- 
topic tracheal revascularization are problematic 
for different reasons. A denervated larynx will 
result in intractable aspiration and orthotopic 
tracheal revascularization will result in unpredict- 
able and insufficient viability. 1-30rthotopic tra- 
cheal revascularization has some disadvantages 
that can influence the revascularization process. 
The shearing movements of respiration and swal- 
lowing prevent close adhesion between graft and 
vascular bed and the regenerating, fragile mucosal 
component is exposed to respiration during early 
revascularization. 
There are reports of successful transplantation f 
five-ring segments in dogs with administration of the 
immunosuppressant FK 5061° or after 10,000 cGy 
irradiation of the allograft. 11 Orthotopic revascular- 
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ization, however, seems length dependent, which 
has led to the statement that tracheal grafts are 
revascularized from their ends rather than from 
their midpo:rtion. 3 
With a combined model of tracheal heterotopic 
revascularization followed by orthotopic transplan- 
tation it is possible to investigate the union between 
donor and recipient tracheas and the histologic 
pathologic onditions can be related to graft func- 
tion within the respiratory process. Another advan- 
tage of this transplantation model is that it allows 
for the study of allograft rejection focused on the 
microcirculation of the transplant. The vascular 
pedicle of the transplant is provided by the receptor 
without the possibility of complications related to 
vascularity that might interfere with the rejection 
process, such as thrombosis of the vascular pedicle 
anastomosis. 
Tracheal orthotopic transplantation after fascial 
revascularization will further be used to test hypoth- 
eses regarding host immune tolerance, tissue pres- 
ervation, and pharmacologic agents. 
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